COMMUNIQUÉS West-GlobeNewswire

-
Teladoc Health Chief Operating Officer and Chief Financial Officer Resigns
17/12/2018 -
Novo Nordisk A/S - Share repurchase programme
17/12/2018 -
Terranueva Corporation to Begin Trading on the Canadian Securities Exchange
17/12/2018 -
Début de la négociation des titres de Corporation Terranueva à la Bourse des valeurs canadiennes
17/12/2018 -
Hemispherx Biopharma Inc. Announces Updated Information about ME/CFS Expanded Access Program in the United States
17/12/2018 -
Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
17/12/2018 -
Uptick Newswire Hosts Progressive Care Inc’s CEO to Discuss an Exciting New Acquisition Prospect and Company Growth
17/12/2018 -
ExCellThera receives FDA orphan drug designation for ECT-001 for the prevention of graft-versus-host disease
17/12/2018 -
Closing of the Transaction of $10,930,000 with Terranueva Pharma Corporation and Concurrent Private Placement of $2,310,000
17/12/2018 -
Clôture de la transaction de 10 930 000 $ avec Corporation Terranueva Pharma et d’un placement privé de 2 310 000 $
17/12/2018 -
Cutera Announces Expansion of FDA Indications for enlighten™ Laser Platform
17/12/2018 -
Physeon Bolsters Management Team with New Appointments
17/12/2018 -
The Governance Institute Announces Governance Technology Partnership with Nasdaq
17/12/2018 -
Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-line NASH Data with Drug Combinations by EASL 2019
17/12/2018 -
PotNetwork Holdings Inc. Prepares for Surge in Interstate Commerce Following 2018 US Hemp Farm Bill
17/12/2018 -
Spectral Announces Results of a Face-to-Face meeting with the U.S. FDA
17/12/2018 -
CLS Holdings USA Positioned for Growth in 2019
17/12/2018 -
Cancer Genetics Terminates Proposed Merger with NovellusDx
17/12/2018 -
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
17/12/2018
Pages